{"disease":{"id":"toxicity","name":"toxicity"},"drugs":{"marketed":[{"drug_id":"fumaria","indication_name":"General toxicity symptom relief","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fumaria","company_name":"Shiraz University of Medical Sciences","drug_phase":"marketed","molecular_target":"","drug_class":"Non-Standardized Food Allergenic Extract [EPC]","quality_score":11,"revenue":null,"mechanism":null},{"drug_id":"hyoscyamine","indication_name":"Cholinesterase Inhibitors Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"(-)-Atropine","generic_name":"Hyoscyamine","company_name":"University of Kansas Medical Center","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M4","drug_class":"hyoscyamine","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"hyoscyamine","indication_name":"Muscarine Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"(-)-Atropine","generic_name":"Hyoscyamine","company_name":"University of Kansas Medical Center","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M4","drug_class":"hyoscyamine","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"antizol","indication_name":"Ethylene Glycol Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Antizol","company_name":"Amgen","drug_phase":"marketed","molecular_target":"Alcohol dehydrogenase, Alcohol dehydrogenase","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"fomepizole","indication_name":"Ethylene Glycol Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Antizol","generic_name":"FOMEPIZOLE","company_name":"Par Pharm Inc","drug_phase":"marketed","molecular_target":"Alcohol dehydrogenase","drug_class":"Antidote [EPC]","quality_score":10,"revenue":null,"mechanism":"Antizol works by competitively inhibiting the enzyme alcohol dehydrogenase, which is responsible for converting toxic alcohols into their more toxic metabolites."},{"drug_id":"acetadote","indication_name":"Contrast Media-Induced Nephrotoxicity Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Acetadote","company_name":"University of Texas Southwestern Medical Center","drug_phase":"marketed","molecular_target":"Cystine/glutamate transporter, Cytochrome c, Glutathione synthetase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"edetic-acid","indication_name":"Digitalis toxicity by EKG","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Calcium Disodium Versenate","generic_name":"EDETIC ACID","company_name":"Medicis","drug_phase":"marketed","molecular_target":"Amyloid beta A4 protein","drug_class":"Anti-coagulant","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"dimercaprol","indication_name":"Gold Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bal","generic_name":"DIMERCAPROL","company_name":"Provepharm Sas","drug_phase":"marketed","molecular_target":"","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"dimercaprol","indication_name":"Mercury Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bal","generic_name":"DIMERCAPROL","company_name":"Provepharm Sas","drug_phase":"marketed","molecular_target":"","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"erdosteine","indication_name":"Mercury Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dithiosteine","generic_name":"ERDOSTEINE","company_name":"","drug_phase":"phase_3","molecular_target":"","drug_class":"erdosteine","quality_score":27,"revenue":null,"mechanism":"Erdosteine works by binding to heavy metals and facilitating their excretion from the body."},{"drug_id":"acetylcysteine","indication_name":"Contrast Media-Induced Nephrotoxicity Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Acetadote","generic_name":"Acetylcysteine","company_name":"Bristol-Myers Squibb","drug_phase":"marketed","molecular_target":"Glutathione levels; reactive metabolite of acetaminophen","drug_class":"Antidote","quality_score":62,"revenue":null,"mechanism":"Acetylcysteine reduces liver injury from acetaminophen overdose by maintaining glutathione levels or providing alternate conjugation substrate."},{"drug_id":"leucovorin","indication_name":"Trimethoprim Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Wellcovorin","generic_name":"leucovorin","company_name":"Pfizer Japan Inc","drug_phase":"marketed","molecular_target":"Dihydrofolate reductase","drug_class":"Folate Analog","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"leucovorin","indication_name":"Methotrexate Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Wellcovorin","generic_name":"leucovorin","company_name":"Pfizer Japan Inc","drug_phase":"marketed","molecular_target":"Dihydrofolate reductase","drug_class":"Folate Analog","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"leucovorin","indication_name":"Pyrimethamine Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Wellcovorin","generic_name":"leucovorin","company_name":"Pfizer Japan Inc","drug_phase":"marketed","molecular_target":"Dihydrofolate reductase","drug_class":"Folate Analog","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"leucovorin","indication_name":"Sulfadiazine Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Wellcovorin","generic_name":"leucovorin","company_name":"Pfizer Japan Inc","drug_phase":"marketed","molecular_target":"Dihydrofolate reductase","drug_class":"Folate Analog","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"leucovorin","indication_name":"Trimetrexate Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Wellcovorin","generic_name":"leucovorin","company_name":"Pfizer Japan Inc","drug_phase":"marketed","molecular_target":"Dihydrofolate reductase","drug_class":"Folate Analog","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"acetylcystein","indication_name":"Contrast Media-Induced Nephrotoxicity Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Acetylcystein","company_name":"University Hospital, Strasbourg, France","drug_phase":"marketed","molecular_target":"Cystine/glutamate transporter, Cytochrome c, Glutathione synthetase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"physostigmine","indication_name":"Anticholinergic Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cogmine","generic_name":"PHYSOSTIGMINE","company_name":"","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"physostigmine","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"l-cysteine","indication_name":"Contrast Media-Induced Nephrotoxicity Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"L-cysteine","company_name":"Louisiana State University Health Sciences Center Shreveport","drug_phase":"marketed","molecular_target":"Cystine/glutamate transporter","drug_class":"Amino acid derivative","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"sodium-thiosulfate","indication_name":"Reduce the risk of ototoxicity associated with cisplatin","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sodium Thiosulfate","generic_name":"SODIUM THIOSULFATE","company_name":"Us Army","drug_phase":"marketed","molecular_target":"cytochrome a3, rhodanese","drug_class":"sodium thiosulfate","quality_score":65,"revenue":null,"mechanism":"Sodium nitrite forms methemoglobin to bind cyanide, while sodium thiosulfate donates sulfur for cyanide conversion to thiocyanate."},{"drug_id":"pralidoxime","indication_name":"Cholinesterase Inhibitors Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pralidoxime Chloride (Autoinjector)","generic_name":"PRALIDOXIME","company_name":"Baxter","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Cholinesterase Reactivator","quality_score":75,"revenue":null,"mechanism":"Pralidoxime Chloride works by reactivating the enzyme acetylcholinesterase, which is inhibited by organophosphate poisoning."},{"drug_id":"levofolinic-acid","indication_name":"Methotrexate Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fusilev","generic_name":"Levofolinic acid","company_name":"Spectrum Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"Folate Analog","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"levofolinic-acid","indication_name":"Pyrimethamine Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fusilev","generic_name":"Levofolinic acid","company_name":"Spectrum Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"Folate Analog","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"levofolinic-acid","indication_name":"Sulfadiazine Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fusilev","generic_name":"Levofolinic acid","company_name":"Spectrum Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"Folate Analog","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"levofolinic-acid","indication_name":"Trimethoprim Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fusilev","generic_name":"Levofolinic acid","company_name":"Spectrum Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"Folate Analog","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"levofolinic-acid","indication_name":"Trimetrexate Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fusilev","generic_name":"Levofolinic acid","company_name":"Spectrum Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"Folate Analog","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"levoleucovorin","indication_name":"Methotrexate Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fusilev","generic_name":"levoleucovorin","company_name":"Acrotech Biopharma","drug_phase":"marketed","molecular_target":"","drug_class":"Folate Analog","quality_score":65,"revenue":null,"mechanism":"Fusilev works by bypassing the enzyme dihydrofolate reductase, allowing normal cell growth and DNA synthesis."},{"drug_id":"levoleucovorin","indication_name":"Pyrimethamine Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fusilev","generic_name":"levoleucovorin","company_name":"Acrotech Biopharma","drug_phase":"marketed","molecular_target":"","drug_class":"Folate Analog","quality_score":65,"revenue":null,"mechanism":"Fusilev works by bypassing the enzyme dihydrofolate reductase, allowing normal cell growth and DNA synthesis."},{"drug_id":"levoleucovorin","indication_name":"Sulfadiazine Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fusilev","generic_name":"levoleucovorin","company_name":"Acrotech Biopharma","drug_phase":"marketed","molecular_target":"","drug_class":"Folate Analog","quality_score":65,"revenue":null,"mechanism":"Fusilev works by bypassing the enzyme dihydrofolate reductase, allowing normal cell growth and DNA synthesis."},{"drug_id":"levoleucovorin","indication_name":"Trimethoprim Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fusilev","generic_name":"levoleucovorin","company_name":"Acrotech Biopharma","drug_phase":"marketed","molecular_target":"","drug_class":"Folate Analog","quality_score":65,"revenue":null,"mechanism":"Fusilev works by bypassing the enzyme dihydrofolate reductase, allowing normal cell growth and DNA synthesis."},{"drug_id":"levoleucovorin","indication_name":"Trimetrexate Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fusilev","generic_name":"levoleucovorin","company_name":"Acrotech Biopharma","drug_phase":"marketed","molecular_target":"","drug_class":"Folate Analog","quality_score":65,"revenue":null,"mechanism":"Fusilev works by bypassing the enzyme dihydrofolate reductase, allowing normal cell growth and DNA synthesis."},{"drug_id":"cysteine","indication_name":"Contrast Media-Induced Nephrotoxicity Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cysteine Hydrochloride","generic_name":"CYSTEINE","company_name":"Exela Pharma","drug_phase":"marketed","molecular_target":"Cystine/glutamate transporter","drug_class":"Vitamin C [EPC]","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"flumazenil","indication_name":"Benzodiazepine Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Romazicon","generic_name":"FLUMAZENIL","company_name":"","drug_phase":"marketed","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-5","drug_class":"Benzodiazepine Antagonist [EPC]","quality_score":51,"revenue":null,"mechanism":""}],"pipeline":[{"drug_id":"phytonadione","indication_name":"Skin toxicity from EGFR inhibitors","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PHYTONADIONE","company_name":"","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase complex subunit 1 (VKORC1)","drug_class":"Vitamin K [EPC]","quality_score":65,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":33,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT05533606","title":"Risk Factors and Machine Learning Model for Beta-Lactam Drugs Related Acute Kidney Injury","phase":"","overall_status":"COMPLETED","enrollment_count":19000,"lead_sponsor_name":"Qianfoshan Hospital","has_results":false},{"nct_id":"NCT05527054","title":"Risk Factors and Machine Learning Model for Diuretics Related Acute Kidney Injury","phase":"","overall_status":"UNKNOWN","enrollment_count":18000,"lead_sponsor_name":"Qianfoshan Hospital","has_results":false},{"nct_id":"NCT06565793","title":"A MAajor RAdiation-based PCI Study in STEMI and NSTEMI","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":15630,"lead_sponsor_name":"Centre Cardiologique du Nord","has_results":false},{"nct_id":"NCT05675111","title":"Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine Immune-related Adverse Events (irAEs)","phase":"","overall_status":"COMPLETED","enrollment_count":12408,"lead_sponsor_name":"Nanjing Medical University","has_results":false},{"nct_id":"NCT05122247","title":"Machine Learning to Predict Acute Care During Cancer Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":12000,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT04002258","title":"Prolactin Change in Chinese Patients With Schizophrenia After Antipsychotics Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":10363,"lead_sponsor_name":"Shanghai Mental Health Center","has_results":false},{"nct_id":"NCT06086132","title":"Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT05533593","title":"Risk Factors and Machine Learning Model for Aminoglycines Related Acute Kidney Injury","phase":"","overall_status":"COMPLETED","enrollment_count":8000,"lead_sponsor_name":"Qianfoshan Hospital","has_results":false},{"nct_id":"NCT04075305","title":"The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study","phase":"","overall_status":"RECRUITING","enrollment_count":8000,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT05885048","title":"Impact of Gonadotoxic Therapies on Fertility","phase":"","overall_status":"RECRUITING","enrollment_count":7000,"lead_sponsor_name":"Michael von Wolff","has_results":false},{"nct_id":"NCT05598879","title":"Global Cardio Oncology Registry","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"The Cleveland Clinic","has_results":false},{"nct_id":"NCT05851222","title":"A Big Data Approach to Predict NEOnatal Acute Kidney Injury in Newborns expoSed to nephroTOxic Drugs (NeoAKI STOP)","phase":"","overall_status":"UNKNOWN","enrollment_count":4200,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT03527615","title":"Clinical Pharmacist Anticoagulant Stewardship","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Hadassah Medical Organization","has_results":false},{"nct_id":"NCT03896139","title":"Identification of PAthways of Kinase Inhibitors TOxicity","phase":"","overall_status":"COMPLETED","enrollment_count":4000,"lead_sponsor_name":"Groupe Hospitalier Pitie-Salpetriere","has_results":false},{"nct_id":"NCT00769223","title":"Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3561,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04499859","title":"Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":3548,"lead_sponsor_name":"Kiyuk Chang, MD,PhD","has_results":false},{"nct_id":"NCT05203250","title":"Longitudinal Registry Including Patients Treated With Heavy Particles","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"CNAO National Center of Oncological Hadrontherapy","has_results":false},{"nct_id":"NCT06531681","title":"Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"The Second Affiliated Hospital of Hainan Medical University","has_results":false},{"nct_id":"NCT03174002","title":"Handling Oxygenation Targets in the Intensive Care Unit","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2928,"lead_sponsor_name":"Aalborg University Hospital","has_results":false},{"nct_id":"NCT03994302","title":"Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX)","phase":"","overall_status":"COMPLETED","enrollment_count":2700,"lead_sponsor_name":"Groupe Hospitalier Pitie-Salpetriere","has_results":false},{"nct_id":"NCT03947034","title":"Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX)","phase":"","overall_status":"COMPLETED","enrollment_count":2700,"lead_sponsor_name":"Groupe Hospitalier Pitie-Salpetriere","has_results":false},{"nct_id":"NCT05094154","title":"Effect of Antibiotic Choice On ReNal Outcomes (ACORN)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2634,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":true},{"nct_id":"NCT04898751","title":"Analysis of Reporting of Cutaneous Toxicities Associated With Immune Checkpoint Inhibitors","phase":"","overall_status":"COMPLETED","enrollment_count":2214,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT05006001","title":"Evaluation of Colchicine and Nonsteroidal Anti-inflammatory Drug Combination Therapy and Renal Function in Gout Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"En Chu Kong Hospital","has_results":false},{"nct_id":"NCT03174236","title":"First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT04209569","title":"One Nutrition in Complex Environments (ONCE)","phase":"NA","overall_status":"COMPLETED","enrollment_count":1834,"lead_sponsor_name":"Tufts University","has_results":false},{"nct_id":"NCT05100784","title":"The Human Sperm Survival Assay (HSSA) as an Internal Quality Control for the IVF Consumables (REPROTOX 2)","phase":"","overall_status":"UNKNOWN","enrollment_count":1800,"lead_sponsor_name":"Ramsay Générale de Santé","has_results":false},{"nct_id":"NCT05146700","title":"Restrictive Vs. Liberal Oxygen in Trauma","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1508,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT04212403","title":"Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB)","phase":"NA","overall_status":"COMPLETED","enrollment_count":1350,"lead_sponsor_name":"Jessa Hospital","has_results":false},{"nct_id":"NCT06512831","title":"Isoniazid Prophylaxis Based on Risk Factors of Tuberculosis in Living Kidney Transplantation Recipients","phase":"NA","overall_status":"COMPLETED","enrollment_count":1348,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT03612544","title":"The ESTxENDS Trial- Substudy on the Effect on Toxins From Using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig)","phase":"NA","overall_status":"COMPLETED","enrollment_count":1246,"lead_sponsor_name":"University of Bern","has_results":false},{"nct_id":"NCT03157336","title":"Cassava Intervention Project","phase":"NA","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"Ministry of Public Health, Democratic Republic of the Congo","has_results":false},{"nct_id":"NCT05161845","title":"Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1068,"lead_sponsor_name":"Shanghai Institute Of Biological Products","has_results":false},{"nct_id":"NCT06503380","title":"Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06357195","title":"DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Ohio State University","has_results":false},{"nct_id":"NCT03316092","title":"Monitoring and Preventing Hydroxychloroquine, Plaquenil, Toxicity.","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Dr. S.S. Michel Clinic","has_results":false},{"nct_id":"NCT04696081","title":"Atrial Fibrillation in Active Cancer Patients","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT03828942","title":"Monitoring the HeMAtological TOXicity of Drugs (HeMATOX)","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Groupe Hospitalier Pitie-Salpetriere","has_results":false},{"nct_id":"NCT05329142","title":"ASSIST: A Surveillance Study of Illicit Substance Toxicity","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"NHS Greater Glasgow and Clyde","has_results":false},{"nct_id":"NCT03629093","title":"Neurodevelopment of Infants Exposed to General Anesthesia: a Multi-center Investigation","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT04233541","title":"Frailty Status and Increased Risk for Falls","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Saglik Bilimleri Universitesi","has_results":false},{"nct_id":"NCT03833297","title":"Monitoring the HePAtological TOXicity of Drugs (HePATOX)","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Groupe Hospitalier Pitie-Salpetriere","has_results":false},{"nct_id":"NCT05492643","title":"The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Zhongnan Hospital","has_results":false},{"nct_id":"NCT01407770","title":"Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT07357636","title":"Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors","phase":"","overall_status":"RECRUITING","enrollment_count":940,"lead_sponsor_name":"Shantou University Medical College","has_results":false},{"nct_id":"NCT03790631","title":"The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring","phase":"","overall_status":"COMPLETED","enrollment_count":771,"lead_sponsor_name":"University of Geneva, Switzerland","has_results":false},{"nct_id":"NCT07083271","title":"Financial Toxicity and Quality of Life in Hospitalized Cancer Patients: A Multicenter Study","phase":"","overall_status":"COMPLETED","enrollment_count":756,"lead_sponsor_name":"Ankara Etlik City Hospital","has_results":false},{"nct_id":"NCT02054741","title":"Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":733,"lead_sponsor_name":"Supriya Mohile","has_results":true},{"nct_id":"NCT04528225","title":"A Prospective Study of Hypothyroidism After Radiotherapy for Breast Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":729,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT04425031","title":"Handling Oxygenation Targets in COVID-19","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":726,"lead_sponsor_name":"Aalborg University Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}